Flexible Non-Dilutive Financing Tied to Specific Biopharmaceutical Products
Mintz represents leading private equity firms, lenders, and other investors and public and private companies in structuring financing transactions around specific drug products and biologics. These transactions include purchases and sales of royalty and milestone interests, synthetic royalty financings, senior secured loans and credit facilities, clinical trial financings, revenue interest financings, accounts receivable financings, purchases and sales of earn-out payments, contingent value rights and priority review vouchers, and other non-dilutive financings.
Mintz has handled dozens of royalty & revenue interest-based financing transactions. Our attorneys utilize structures and terms that help our clients most effectively achieve their goals for engaging in the transaction.
Our attorneys collaborate with you to identify the transaction terms and structures that will position you to secure the result you're looking for from your deal.